Wednesday, 14 October 2026
IV iron and delivery transfusions, Cannabis-related admissions rise, Contaminated kits removed
- 01
IV iron linked to fewer delivery transfusions in pregnancy
A meta-analysis of almost 12,000 pregnant women with diagnosed iron deficiency anaemia found IV iron was associated with higher maternal haemoglobin and ferritin at delivery and a 37% reduction in blood transfusions during delivery hospitalisation compared with oral iron. IV iron was also associated with faster correction of anaemia, better infant ferritin stores and 43% fewer side effects, particularly gastrointestinal effects. The analysis found no significant differences in birth weight or gestational age at delivery. Australian guidance currently recommends oral iron as first-line therapy and generally does not recommend IV iron in the first trimester, although it may be considered from the second trimester for intolerance, poor response or when faster correction is required. RACGP NSW&ACT Chair Dr Rebekah Hoffman said the findings may prompt a guideline rethink, while cost, monitoring requirements and the lack of a dedicated MBS item remain barriers to infusions in general practice.
via RACGP newsGP
- 02
Victorian cannabis-related hospital admissions rose 49% over decade
Cannabis-related hospital admissions in Victoria increased by 49% from July 2013 to June 2023, a retrospective observational study found. Almost 40,000 admissions occurred during the decade, with the highest rates among people aged 15–24 years; admissions rose by 75% among women and girls and 35% among men. Psychotic disorder was the most common principal diagnosis, accounting for 40.1%, while more than two-thirds of admissions involved multi-day stays and more than 1500 required intensive care. Admission rates peaked in 2020–21, coinciding with COVID-19 lockdowns. The study did not distinguish illicit from prescribed medicinal cannabis or identify polypharmacy and other substance use, so it could not establish that medicinal cannabis drove the increase.
via RACGP newsGP
- 03
Medline kits removed over potential fungal contamination
Certain Medline convenience kits containing recalled BD ChloraPrep applicators should be removed from use because of potential fungal contamination, according to FDA MedWatch. The action affects Medline kits that include the recalled applicators. The source gives limited detail and does not specify affected kit identifiers or the extent of the recall.
via FDA MedWatch
- 04
UN adopts pandemic declaration without pathogen benefit-sharing consensus
The UN adopted a political declaration on pandemic prevention, preparedness and response, but members failed to agree on how benefits from products created using shared pathogen data would be distributed. Months of negotiations did not resolve the terms of the Pathogen Access and Benefit Sharing annex ahead of a high-level meeting on 25 September. Without the annex, the accord cannot be fully formalised and is not legally binding. Talks stalled amid a stand-off between coalitions representing low- and middle-income countries in Africa, Latin America and Asia, and some high-income European nations together with the United States.
via BMJ
- 05
Updated US stroke guideline calls for early holistic rehabilitation
Stroke rehabilitation should start as early as possible and be tailored to patients’ physical, cognitive, language and emotional needs, according to updated 2026 guidance from the American Heart Association and American Stroke Association. The source gives limited detail beyond the guideline’s emphasis on early, holistic and personalised rehabilitation.
via JAMA
- 06
FDA approves two Alzheimer disease blood tests
The US Food and Drug Administration approved two blood tests to detect Alzheimer disease in adults with cognitive symptoms. One test is approved for adults as young as 40 years. The approvals introduce blood-based testing for this symptomatic population. The source gives limited detail about the tests or their indications.
via JAMA
MDDR is a news digest for medical professionals. It is not medical advice and should not be relied on for clinical decision-making.